Quality of Life in Sarcopenia and Frailty René RizzoliJean-Yves ReginsterOlivier Bruyère Review 05 July 2013 Pages: 101 - 120
Involvement of WNT/β-catenin Signaling in the Treatment of Osteoporosis Maurizio RossiniDavide GattiSilvano Adami Review 11 June 2013 Pages: 121 - 132
Testosterone Levels Following Decreases in Serum Osteocalcin Mark J. BollandAndrew GreyIan R. Reid Original Research 19 April 2013 Pages: 133 - 136
Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis Toshitaka NakamuraTetsuo NakanoFor the MOVER Study Group Original Research Open access 05 May 2013 Pages: 137 - 146
Association of n-3 Polyunsaturated Fatty Acid Intake with Bone Mineral Density in Postmenopausal Women Kiyoko NawataMika YamauchiToshitsugu Sugimoto Original Research 26 May 2013 Pages: 147 - 154
Dosage Effect of a Phex Mutation in a Murine Model of X-Linked Hypophosphatemia Shoji IchikawaAmie K. GrayMichael J. Econs Original Research 23 May 2013 Pages: 155 - 162
The Role of the Serum Vitamin D Binding Protein in the Actions of the Vitamin D Analog Eldecalcitol (ED-71) on Bone and Mineral Metabolism Alex J. BrownFanjie ZhangCynthia S. Ritter Original Research 22 May 2013 Pages: 163 - 171
Bone Selective Protective Effect of a Novel Bone-seeking Estrogen on Trabecular Bone in Ovariectomized Rats Qiang ZhaoXiaodong LiuLianfu Deng Original Research Open access 19 June 2013 Pages: 172 - 183
Low Protein Intake Magnifies Detrimental Effects of Ovariectomy and Vitamin D on Bone Clarisa MarotteMacarena M. S. Gonzales ChavesSusana N. Zeni Original Research 26 May 2013 Pages: 184 - 192
Erratum to: Recommendations for the Health Economics Analysis to be Performed with a Drug to be Registered in Prevention or Treatment of Osteoporosis W. DereB. AvouacJ. Y. Reginster Erratum 05 July 2013 Pages: 193 - 193
